Redox Webinar Series 2022
Redox2022 Webinar detailed Programme
Thursday 7 July 2022 - NRF2 and metabolic diseases
Organized in cooperation with the COST action CA20121
“Bench to Bedside transition for Pharmacological regulation of NRF2 in non communicable diseases”
AMP(K)lifying Nrf2: The crosstalk between Nrf2 and the metabolic master hub AMPK
by Elke H Heiss, Department of Pharmaceutical Sciences at the University of Vienna in Austria.
Translational implications of Nrf2 signaling in the thyroid
by Gerasimos (Gerry) Sykiotis, Faculty of Biology and Medicine of the University of Lausanne, and Service of Endocrinology, Diabetology and Metabolism at Lausanne University Hospital.
Cholesterol Mediated Nrf2 Status in NASH Development: Role of α-Tocopherol
by Nesrin Kartal Ozer, Marmara University, Faculty of Medicine, Department of Biochemistry, Istanbul, Turkey.